Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The peptide incorporates two key structural modifications: (i) substitution of alanine with 2-aminoisobutyric acid (Aib) at position 8 , which confers resistance to dipeptidyl peptidase-4 (DPP-4) degradation and extends peptide stability in vivo
Semaglutide and Tirzepatide are injectable medications originally designed to treat Type 2 diabetes
Meanwhile, scientists continue to research new treatment approaches
Cagrilintide 5mg key specifications Compound: Cagrilintide (long-acting amylin analogue) Strength: 5mg per vial CAS number: 1949837-12-0 Molar mass: ~3754 g/mol Purity: 99% (HPLC, third-party verified) Form: Lyophilised powder single sealed vial Commonly researched with Researchers often study Cagrilintide 5mg in parallel with our Semaglutide and wider GLP-1 research range when modelling combined receptor pathways
US$ 24.73
US$ 26.50
US$ 20.02
